Open access
Jul 2026
UBTD1: a prognostic and immune biomarker validated in thyroid cancer and pan-cancer analysis
UBTD1 can be used as a biomarker of important clinical value in pan-cancer and the expression and role of UBTD1 in THCA is clarified, indicating that the overexpression of UBTD1 is prevalent in many cancers and correlates with poor prognosis.
Baoguo Xu, Yue Zhang, Xia Yu et al.
· Frontiers in Oncology · 0 citations